Appellate Court Reverses Meso Verdict, Cites BorgWarner Standards
July 26, 2007
DOCUMENTS
- Opinion
HOUSTON -- A Texas appellate court has reversed a $6 million verdict because the plaintiffs failed to quantify the amount of exposure specifically to Georgia-Pacific's joint compound products in accordance with new standards outlined in the Supreme Court's decision in BorgWarner v. Flores. Georgia-Pacific Corp. v. Stephens, et al., No. 01-05-00132 (Texas 1st Dist. Ct. App.).
In the July 26 opinion, the Texas First District Court of Appeals opined that the plaintiffs' experts failed to quantify evidence of exposure and provide evidence of a minimum exposure level, justifying a reversal of the verdict.
"Applying the Texas Supreme Court's test …
UPCOMING CONFERENCES
HarrisMartin’s Artificial Stone Silicosis Epidemic Litigation Conference
January 10, 2025 - Long Beach, CA
The Westin Long Beach